Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ/Daiichi Sankyo’s antibody drug conjugates prove promising in early trials

pharmatimesJanuary 29, 2021

Tag: AstraZeneca , Daiichi Sankyo , Enhertu , datopotamab deruxtecan , NSCLC

PharmaSources Customer Service